Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -77.85% | 22,242.86% | |||
| Gross Profit | 77.85% | -22,242.86% | |||
| SG&A Expenses | -3.11% | 11.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.42% | 10.36% | |||
| Operating Income | 5.42% | -10.36% | |||
| Income Before Tax | 13.48% | -30.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.48% | -30.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.48% | -30.23% | |||
| EBIT | 5.42% | -10.36% | |||
| EBITDA | 5.22% | -10.91% | |||
| EPS Basic | 13.56% | -30.19% | |||
| Normalized Basic EPS | -27.23% | 11.56% | |||
| EPS Diluted | 13.56% | -30.19% | |||
| Normalized Diluted EPS | -27.23% | 11.56% | |||
| Average Basic Shares Outstanding | 0.08% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||